← Back to Search

TMH Intervention for Injury

N/A
Waitlist Available
Led By Ben Zarzaur, MD, MPH
Research Sponsored by Indiana University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 and 12 months
Awards & highlights

Study Summary

This trial will compare a collaborative care intervention to usual care in 430 injury survivors 50 and older to see if it can improve physical and psychological recovery, as well as reduce healthcare costs.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 and 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Healthcare Utilization
Change in Physical Recovery
Change in Self Reported Physical Recovery
+1 more
Secondary outcome measures
Change in Anxiety Symptoms
Change in Depression Symptoms
Cost effectiveness

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: TMH InterventionExperimental Treatment1 Intervention
The multidisciplinary team which develops and carries out the intervention includes a care coordinator who will organize and align recovery resources, a Trauma Surgeon (Dr. Zarzaur), a critical care physician (Dr. Khan), a geriatrician with expertise in collaborative care (Dr. Boustani), and an ICU collaborative care nurse (Dr. Lasiter). Using the Healthy Aging Brain Care monitor, care protocols, specialized software, and specific care protocols, the multidisciplinary team will modulate the intensity and the type of intervention the patient's receive based on the patient's needs. The intervention will last from the time of discharge to 6 months after injury.
Group II: Usual CareActive Control1 Intervention
Review hospital discharge and rehabilitation plan, identify the primary care physician responsible for the patient care. Patients will receive education on communication skills; caregiver coping skills; and legal and financial advice. Patients randomized to usual care will receive no further interventions.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
TMH Intervention
2017
N/A
~430

Find a Location

Who is running the clinical trial?

University of Missouri, Kansas CityOTHER
68 Previous Clinical Trials
32,174 Total Patients Enrolled
Indiana UniversityLead Sponsor
980 Previous Clinical Trials
982,731 Total Patients Enrolled
Northwestern UniversityOTHER
1,585 Previous Clinical Trials
916,801 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the enrollment period open for this experiment?

"Per the information on clinicaltrials.gov, volunteers are being recruited for this experiment that was first published on October 1st 2017 and recently updated in February 2019."

Answered by AI

What is the sample size of participants in this clinical trial?

"Affirmative. According to the official records on clinicaltrials.gov, this medical research first went live in October 2017 and was revised in February 2019; 430 subjects must be recruited from 3 trial sites for it to proceed as planned."

Answered by AI
~57 spots leftby Apr 2025